POLISH CARDIAC SOCIETY WEB SITE

5th INTERNATIONAL CONGRESS

of the POLISH CARDIAC SOCIETY

Warsaw, 27-29 of September, 2001


MORE INFORMATION ABOUT WARSAW
BACK TO HOMEPAGE LINKS MEDLINE M@IL US NEWS POLISH VERSION

 

  back to PROGRAM

THE NATIONAL THEATRE

THURSDAY, 27 of September, 2001 FRIDAY, 28 of September, 2001 SATURDAY, 29 of September, 2001

 


THURSDAY, 27 of September, 2001

THURSDAY, 10:00-11:30
BOGUSŁAWSKI HALL    "PRZY UL. WIERZBOWEJ" HALL
Session of the Working Group on Echocardiography
4

Session of the Working Group on Resuscitation
 5

Tissue Doppler echocardiography: diagnostic tool or scientific method?
Chairpersons:
     J. Kasprzak (Łódź)
     A. Klisiewicz (Warszawa)

Ventricular fibrillation.
Chairpersons:
     A. Mysiak (Wrocław)
     A. Górecki (Warszawa)

- Panel discussion:
     J. Drożdż (Łódź)
      M. Hlawaty (Kraków)
     M. Kowalski (D)
     M. Plewka (Łódź)

 - Electrophysiology of ventricular arrhythmia.
     A. Beręsewicz (Warszawa)                                  20'
- New opinion about genesis and efficacy of ventricular fibrillation prophylaxis and therapy.
     A. Mysiak (Wrocław)                                            20'
- Vasopressin in resuscitation.
     A. Górecki (Warszawa)                                         15'

- New guidelines of European Resuscitation Council (ERC) 2000.
     M. Kobusiak-Prokopowicz (Wrocław)                   15'
- Discussion

top of the page

11:30-12:00

BREAK

THURSDAY, 12:00-13:30
BOGUSŁAWSKI HALL    " PRZY UL. WIERZBOWEJ" HALL
Satellite Session of Berlin-Chemie Company
11		 Session of the Working Group
on Coronary Heart Disease in Women
12
Nebivolol - why more than b-blocker?
Chairperson:
     R. Gryglewski (Kraków)		 Pregnancy and cardiovascular diseases.
Chairpersons:
     M. Krzemińska-Pakuła (Łódź)
     Z. Kornacewicz-Jach (Szczecin)

- Role of nitric oxide and prostacycline in endothelial drug activity.
     R. Gryglewski (Kraków)

- Arterial hypertension in pregnant women.
     M. Krzemińska-Pakuła (Łódź)             20'

- Triumphal return of beta adrenolytics.
     Z. Gaciong (Warszawa)

 - CHD in pregnant women (pathogenesis, diagnostics, therapy).
     J. Kłoś (Warszawa)                              15'

- Hemodynamic and vascular action of beta adrenolytics.
     T. Pasierski (Warszawa)

- Arrhythmia in pregnant women.
     G. Świątecka (Gdańsk)                         20'

- Nebivolol, a beta adrenolytic with unique properties.
     D. Liszewska-Pfejfer (Warszawa)

- Pregnancy in women with cardiac defect.
      W. Tracz (Kraków)                               20'
  - Discussion                                                   15'


top of the page

13:30-14:30
BREAK

FRIDAY, 28 of September 2001

FRIDAY, 9:00-10:30
BOGUSŁAWSKI HALL    " PRZY UL. WIERZBOWEJ" HALL
Session of the Polish Cardiac Society
and French Society of Cardiology
18		 Abstract Session
19

Prevention of the high cardiovascular risk patients.
Chairpersons:
     W. Rużyłło (Warszawa)
     J-P. Fauchier (Tours, F)

Implantable cardioverter-defibrillators.
Chairpersons:
      M. Trusz-Gluza (Katowice)
      R. Hatala (Bratislava, SK)

- Coronary prevention.
     N. Danchin (Vandoeuvre, F)

- Is heart failure a preventable disease?
     P. Ponikowski (Wrocław)

- Stroke prevention.
     M-G. Bousser (Paris, Francja)

- Hypertension and cardiovascular diseases - new approaches to reduce the risk.
     K. Narkiewicz (Gdańsk)


top of the page

10:30-11:00
BREAK

FRIDAY, 11:00-12:30

BOGUSŁAWSKI HALL    " PRZY UL. WIERZBOWEJ" HALL
Satellite Session of Schwarz Pharma Company
 37		 Session of the Polish Cardiac Society
and Polish Chapter of ISPOR
38
To prolong life or to improve its quality?
Chairperson:
     M. Dłużniewski (Warszawa)		 Pharmacoeconomics.
Chairpersons:
     G. Opolski (Warszawa)
     A. P. Mazurek (Warszawa)
- From reserpine to statins - pharmacological revolution in cardiology of the 20th century.
     L. Poloński (Zabrze)                        20'		 - Medicine of standards and costs of treatment - "everything" for "everybody"?
     G. Opolski (Warszawa)                                  10'

- From talcing to stents - revolutin in invasive cardiology.
      Z. Kornacewicz-Jach (Szczecin)     20'

 - Pharmacoeconomics of coronary heart disease.
     J. J. Fedorowski (Vermont, USA)                   20'
- It is better to prevent than to treat - cardiological risk factors.
      K. Kawecka-Jaszcz (Kraków)         20'		 - New methods of profitability evaluation of arterial hypertension with complications.                                                        20'
     J. Spławiński (Warszawa)
     J. Kuźniar (Rzeszów)
- We live longer - let's live better.
     W. Januszewicz (Warszawa)         20'

- The class effect in clinical pharmacology and pharmacoeconomics.
     K. J. Filipiak (Warszawa)                                20'
     M. Niewada (Warszawa)
- Perspectives of pharmacoeconomical analysis in Poland.
     P. Sztwiertnia (Warszawa)                           20'
- Summary:                                                          20'
     G. Opolski (Warszawa)
     A. P. Mazurek (Warszawa)
     J. J. Fedorowski (Vermont, USA)

top of the page
12:30-14:00
BREAK

FRIDAY, 14:00-15:30

BOGUSŁAWSKI HALL    " PRZY UL. WIERZBOWEJ" HALL
Satellite Session of Bayer Company
44		 Abstract Session
45

Statins - can we expect more?
Chairperson:
      M. Tendera (Katowice)

Coronary heart disease - metabolic aspects.
Chairpersons:
     Z. Sadowski (Warszawa)
     K. Wrabec (Wrocław)

- Discussion participants:
      R. Gryglewski (Kraków)
     M. Tendera (Katowice)
      Z. Kornacewicz-Jach (Szczecin)
     A. Więcek (Katowice)


top of the page
15:30-16:00
BREAK

FRIDAY, 16:00-17:30

BOGUSŁAWSKI HALL    " PRZY UL. WIERZBOWEJ" HALL
Satellite Session
of Abbott Laboratories Company
62		 Abstract Session
63

Cardiovascular diseases - pharmacotherapy of the coming decade.
Chairperson:
          G. Opolski (Warszawa)

Invasive treatment of coronary heart disease.
Chairpersons:
     Z. Kornacewicz-Jach (Szczecin)
     P. Buszman (Katowice)
- Sympathetic system in cardiovascular diseases - modification possibilities.
     K. Narkiewicz (Gdańsk)

- The art of individualization of therapy in patients with stable angina.
     W. Banasiak (Wrocław)

- Heart failure prevention - main point in cardiovascular diseases therapy.
     G. Opolski (Warszawa)

- Discussion of clinical cases.

top of the page
17:30-18:00
BREAK

FRIDAY, 18:00-19:30

BOGUSŁAWSKI HALL    " PRZY UL. WIERZBOWEJ" HALL
Satellite Session
of Merck Sharp & Dohme Company
69		 Abstract Session
70

Statins - only cardiological treatment?
Chairperson:
     A. Cieśliński (Poznań)

Long-term results of coronary heart disease treatment.
Chairpersons:
     R. Gil (Szczecin)
     S. Woś (Katowice)

- Statins - a dream about panacea.
     A. Szczeklik (Kraków)

- Statins in diabetes treatment.
     P. Ponikowski (Wrocław)

- Statins in cerebral stroke prevention.
     A. Członkowska (Warszawa)


top of the page

SATURDAY, 29 of September 2001

SATURDAY, 9:00-10:30
BOGUSŁAWSKI HALL    " PRZY UL. WIERZBOWEJ" HALL
Satellite Session of Aventis Company
76		 Abstract Session
77

Evidence Based Medicine - method of drug comparison and selection.
Chairperson:
     G. Opolski  (Warszawa)

Cardiosurgical treatment of coronary heart disease.
Chairpersons:
     A. Bochenek (Katowice)
     Z. Juraszyński (Warszawa)

- Evidence Based Medicine - guidelines for acute coronary syndrome according to AHA and ESC.
     J. Górski (Gdynia)

- Evidence Based Medicine - angiotensin converting enzyme inhibitors in prevention of cardiovascular events.
     G. Opolski (Warszawa)

- Evidence Based Medicine - are all low molecular weight heparines equal?
     K. J. Filipiak (Warszawa)


top of the page
10:30-11:00
BREAK

SATURDAY, 11:00-12:30

BOGUSŁAWSKI HALL    " PRZY UL. WIERZBOWEJ" HALL
Session of the Polish Cardiac Society
(PRO-CONTRA Session)
93		 Abstract Session
94

Debates from the series:
"Controversies in cardiology and cardiosurgery".
Chairpersons:
     S. Woś (Katowice)
     Z. Religa (Warszawa)
Treatment of acute myocardial infarction.
Chairpersons:
     J. Kuch (Warszawa)
     J. Stępińska (Warszawa)

- Multivessel coronary heart disease - CABG versus PTCA.
     M. Zembala (Zabrze)
     P. Buszman (Katowice)

- Proximal stenosis of LAD - operation versus implantation?
     A. Witkowski (Warszawa)
     A. Bochenek (Katowice)

top of the page
12:30-13:00
BREAK

SATURDAY, 13:00-14:30

BOGUSŁAWSKI HALL    " PRZY UL. WIERZBOWEJ" HALL
Session of the Polish Cardiac Society
100		 Working Group "30 Club"
101

Invasive cardiology - management in selected groups of patients.
Chairpersons:
     A. Witkowski (Warszawa)
     K. Żmudka (Kraków)

Risk stratification in patients after myocardial infarction - perspectives of the 21st century.
Chairpersons:
     J. Kasprzak (Łódź)
     M. Kuch (Warszawa)
- Acute myocardial infarction.
     L. Poloński (Zabrze)

- Role of echocardiography in management stratification in patients after myocardial infarction.
     M. Szulc (Warszawa)

- Patients with CAD and diabetes.
     M. Lesiak (Poznań)

- Turbulence of cardiac sinus rhythm - a new electrocardiographic indicator in patients after myocardial infarction.
     P. Guzik (Poznań)

- Patients dialysed because of chronic renal failure.
     A. Witkowski (Warszawa)

 - Role of neurohormonal markers and cytokines.
     W. Kosmala (Wrocław)

- Prevention of central nervous system stroke in patients with atrial septal defect.
     M. Demkow (Warszawa)

 - Is invasive treatment necessary for each patient after myocardial infarction?
     D. Dudek (Kraków)
- Discussion

top of the page